Αναζήτηση Δραστικών

CARBETOSIN

Εμπορικές Ονομασίες

  • PABAL
    Μορφές: INJ.SOL
  • DRUGBANK - Carbetocin
  • indication:

    Used to control postpartum hemorrhage and bleeding after giving birth.

  • pharmacology:

  • mechanism:

    Carbetocin binds to oxytocin receptors present on the smooth musculature of the uterus, resulting in rhythmic contractions of the uterus, increased frequency of existing contractions, and increased uterine tone. The oxytocin receptor content of the uterus is very low in the non-pregnant state, and increases during pregnancy, reaching a peak at the time of delivery.

  • toxicity:

  • absorprion:

    Bioavailability is 80% following intramuscular injection.

  • halflife:

    40 minutes

  • roouteelimination:

  • volumedistribution:

  • clearance: